FYB Formycon AG

15.36USD14.00 EUR · XETRA-3.45%Mkt Cap: 271.37M USDP/E: —

Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland. It provides ranibizumab and aflibercept used in the treatment of neovascular age-related macular degeneration, diabetic macular …